ABSTRACT NUMBER: ESOC2026A1252 INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE PATIENTS ON DIRECT ORAL ANTICOAGULANTS UNDERGOING ENDOVASCULAR THROMBECTOMY
Marius Matusevicius, Ana Paiva Nunes, Andrea Zini, Guido Bigliardi, André Peeters, Danilo Toni, Niaz Ahmed · 2026
Read ABSTRACT NUMBER: ESOC2026A1252 INTRAVENOUS THROMBOLYSIS IN ACUTE ISCHEMIC STROKE PATIENTS ON DIRECT ORAL ANTICOAGULANTS UNDERGOING ENDOVASCULAR THROMBECTOMY by Marius Matusevicius, Ana Paiva Nunes, Andrea Zini, Guido Bigliardi, André Peeters, Danilo Toni, Niaz Ahmed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146687.txt.
Description
Marius Matusevicius and co-authors weigh stroke treatment in patients on blood thinners in 2026. A clot busting drug given before clot removal is standard in many stroke cases. Its need has been questioned, most of all for patients already on direct oral anticoagulants. Bleeding in the brain is the feared trade off.
The team used a large international stroke registry for the comparison. Patients on thinners who got both treatments were matched with those who got removal alone. Outcomes covered independence at three months, brain bleeding, and death. The results help doctors judge a risky call made under time pressure.
Catalog record
| CREATOR | Marius Matusevicius, Ana Paiva Nunes, Andrea Zini, Guido Bigliardi, André Peeters, Danilo Toni, Niaz Ahmed |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |